Renal function in relation to three candidate genes in a Chinese population

Journal of Molecular Medicine

Volumn 82, Issue 10, 2004, Pages 715-722

  Wang, Ji Guang ^a,b,d,f   Liu, Lifang ^b   Zagato, Laura ^c   Xie, Jinxiang ^b   Fagard, Robert ^d   Jin, Kugen ^e   Wang, Jinxiang ^d,e   Li, Yan ^a   Bianchi, Giuseppe ^c   Staessen, Jan A ^d   Liu, Lisheng ^b,g  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e Gaoping City Hospital   (China)

^f ZHENGZHOU UNIVERSITY   (China)

^g PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Adducin gene; Aldosterone synthase; Angiotensin converting enzyme; Renal function; Serum creatinine

Indexed keywords

ADDUCIN; ALDOSTERONE SYNTHASE; ALPHA ADDUCIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; GENE PRODUCT; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ALLELE; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; CANDIDATE GENE; CHINESE; CHINESE POPULATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FAMILY STUDY; FEMALE; GENE; GENERALIZED ESTIMATING EQUATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAN CHINESE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; NORMAL HUMAN; POPULATION GENETICS; POPULATION RESEARCH; QUANTITATIVE TRANSMISSION DISEQUILIBRIUM TEST; URIC ACID BLOOD LEVEL;

ADULT; ALDOSTERONE SYNTHASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; CHINA; CREATININE; FEMALE; GENETICS, POPULATION; HOMOZYGOTE; HUMANS; KIDNEY FUNCTION TESTS; MALE; PEDIGREE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; URIC ACID;

EID: 7944222235     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0574-8     Document Type: Article

References (49)

1. Wang JG, et al (2001) Renal function in relation to three candidate genes. Am J Kidney Dis 38:1158-1168
2. Balkestein EJ, et al (2002) Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens 20:1551-1561
3. Staessen JA, et al (2001) Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19:1349-1358
4. Balkestein EJ, et al (2001) Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 38:1190-1197
5. Wang JG, Staessen JA (2000) Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 410:289-302
6. Matsubara M, et al (2002) Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens 19:2179-2184
7. Sugimoto K, et al (2001) Alpha-adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama Study. J Hypertens 20:1779-1784
8. He X, et al (2001) α-Adducin gene and essential hypertension in China. Clin Exp Hypertens 23:579-589
9. Kunz R, et al (1998) Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy: a methodologie appraisal and systematic review. J Am Soc Nephrol 9:1653-1663
10. Brand E, et al (1998) Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32:198-204
11. Manunta P, et al (1999) Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33:694-697
12. Barlassina C, et al (2000) Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 57:1083-1090
13. Johnson RJ, et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular disease? Hypertension 41:1183-1190
14. Stolarz K, et al (2003) Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens 21:525-535
15. Kuznetsova T, et al (2002) Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 7:215-224
16. Morgan L, et al (1999) Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies. J Hypertens 17:765-768
17. Alberti KGMM, et al (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553
18. Praetorius E (1949) Enzymatic method for determination of uric acid by ultraviolet spectrophotometry. Scand J Clin Lab Invest 1:222-230
19. Gehan EA, George SL (1970) Estimation of human body surface area from height and weight. Cancer Chemother Rep 54:225-235
20. Kvist H, et al (1988) Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 48:1351-1361
21. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
22. Livak KJ, et al (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4:357-362
23. Zeger SL, et al (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049-1060
24. Abecasis GR, et al (2000) A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279-292
25. Abecasis GR, et al (2001) Association analysis in a variance components framework. Genet Epidemiol 21 [Suppl 1]:S341-S346
26. Rossi GP, et al (2001) Exclusion of the ACE D/I gene polymorphism as a determinant of endothelial dysfunction. Hypertension 37:293-300
27. Matsubara M, et al (2002) Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study. J Hypertens 20:1121-1126
28. Lee YJ, Tsai JCR (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25:1002-1008
29. Yildiz A, et al (2002) The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant 16:173-179
30. Kario K, et al (1998) Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients. J Am Coll Cardiol 32:444-450
31. Rigat B, et al (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
32. Danser AHJ, et al (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388
33. Müller DN, et al (1997) Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 29:98-104
34. Moriwaki Y, et al (2002) Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol. Metabolism 51:893-895
35. van der Kleij FGH, et al (2002) Enhanced responses of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. J Am Soc Nephrol 13:1025-1033
36. Messerli FH, et al (1980) Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 93:817-821
37. Curnow KM, et al (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5:1513-1522
38. Clyne CD, et al (1997) Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements. Mol Endocrinol 11:638-649
39. Pitt B, et al (1999) The effect of spironolactone on morbidity and mortality in patients with sever heart failure. N Engl J Med 341:709-717
40. Pitt B, et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
41. Lim PO et al. (2002) Variation in the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio. J Clin Endocrinol Metab 87:4398-4402
42. Katsuya T, et al (2003) Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 26:521-525
43. Wang JG, et al (2001) Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37:1069-1074
44. de Leeuw PW, et al (2002) Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur Trial. J Am Soc Nephrol 13:2213-2222
45. Culleton BF, et al (1999) Prevalence and correlates of elevated serum creatinine levels. The Framingham Heart Study. Arch Intern Med 159:1785-1790
46. Culleton BF, et al (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7-13
47. Freedman DS, et al (1995) Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 141:637-644
48. Jones CA, et al (1998) Serum creatinine levels in the US populations: third National Health and Nutrition Exmination Survey. Am J Kidney Dis 32:992-999
49. Wang JG, Staessen JA (2002) Raised concentrations of serum creatinine and uric acid and the risks of mortality and cardiovascular disease. Cardiovasc Rev Rep 23:393-397